Cooperation between cyclin E and p27Kip1 in pituitary tumorigenesis

Molecular Endocrinology

Volumn 24, Issue 9, 2010, Pages 1835-1845

  Roussel Gervais, Audrey ^a   Bilodeau, Steve ^a   Vallette, Sophie ^a   Berthelet, France ^b   Lacroix, André ^b   Figarella Branger, Dominique ^c   Brue, Thierry ^d   Drouin, Jacques ^a  

^a Rehabilitation Institute of Montreal   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRG1 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; PROOPIOMELANOCORTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CENTROSOME; CONTROLLED STUDY; CUSHING DISEASE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR VOLUME; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL PROLIFERATION; CENTROSOME; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA HELICASES; GENE KNOCKDOWN TECHNIQUES; HYPERPLASIA; MICE; MICE, TRANSGENIC; NUCLEAR PROTEINS; PHENOTYPE; PITUITARY ACTH HYPERSECRETION; PITUITARY GLAND; PITUITARY NEOPLASMS; PRECANCEROUS CONDITIONS; PRO-OPIOMELANOCORTIN; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS;

EID: 77956103451     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0091     Document Type: Article

References (55)

1. 1-phase progression. Genes Dev 13:1501-1512
2. Franklin DS, Godfrey VL, Lee H, Kovalev GI, Schoonhoven R, Chen-Kiang S, Su L, Xiong Y 1998 CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev 12:2899-2911 (Pubitemid 28440148)
3. Latres E, Malumbres M, Sotillo R, Martín J, Ortega S, Martín-Caballero J, Flores JM, Cordón-Cardo C, Barbacid M 2000 Limited overlapping roles of p15(INK4b) and p18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. EMBO J 19:3496-3506 (Pubitemid 30428227)
4. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, Kaushansky K, Roberts JM 1996 A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85:733-744 (Pubitemid 126334353)
5. Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA, Koff A 1996 Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85:721-732 (Pubitemid 126334352)
6. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY, Nakayama K 1996 Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720 (Pubitemid 126334351)
7. Chien WM, Rabin S, Macias E, Miliani de Marval PL, Garrison K, Orthel J, Rodriguez-Puebla M, Fero ML 2006 Genetic mosaics reveal both cell-autonomous and cell-nonautonomous function of murine p27Kip1. Proc Natl Acad Sci USA 103:4122-4127
8. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA 1992 Effects of an Rb mutation in the mouse. Nature 359:295-300
9. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE 2004 The prevalence of pituitary adenomas: a systematic review. Cancer 101:613-619 (Pubitemid 38970613)
10. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M 2003 Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593-5602 (Pubitemid 38033020)
11. Philips A, Maira M, Mullick A, Chamberland M, Lesage S, Hugo P, Drouin J 1997 Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Mol Cell Biol 17:5952-5959 (Pubitemid 27411102)
12. Svec F 1984 Glucocorticoids inhibit the growth of AtT-20 mouse pituitary tumor cells. Mol Cell Endocrinol 35:33-40
13. Bilodeau S, Vallette-Kasic S, Gauthier Y, Figarella-Branger D, Brue T, Berthelet F, Lacroix A, Batista D, Stratakis C, Hanson J, Meij B, Drouin J 2006 Role of Brg1 and HDAC2 in GR trans-repression of pituitary POMC gene and misexpression in Cushing disease. Genes Dev 20:2871-2886
14. Reisman DN, Sciarrotta J, Wang W, Funkhouser WK, Weissman BE 2003 Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Res 63:560-566
15. Gunduz E, Gunduz M, Ouchida M, Nagatsuka H, Beder L, Tsujigiwa H, Fukushima K, Nishizaki K, Shimizu K, Nagai N 2005 Genetic and epigenetic alterations of BRG1 promote oral cancer development. Int J Oncol 26:201-210
16. Zhang HS, Gavin M, Dahiya A, Postigo AA, Ma D, Luo RX, Harbour JW, Dean DC 2000 Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101:79-89
17. Sherr CJ, Roberts JM 2004 Living with or without cyclins and cyclin-dependent kinases. Genes Dev 18:2699-2711
18. Vlach J, Hennecke S, Amati B 1997 Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J 16:5334-5344
19. Hanashiro K, Kanai M, Geng Y, Sicinski P, Fukasawa K 2008 Roles of cyclins A and E in induction of centrosome amplification in p53-compromised cells. Oncogene 27:5288-5302
20. Iida H, Towatari M, Tanimoto M, Morishita Y, Kodera Y, Saito H 1997 Overexpression of cyclin E in acute myelogenous leukemia. Blood 90:3707-3713 (Pubitemid 27473442)
21. Erlanson M, Landberg G 2001 Prognostic implications of p27 and cyclin E protein contents in malignant lymphomas. Leuk Lymphoma 40:461-470 (Pubitemid 32303237)
22. Jordan S, Lidhar K, Korbonits M, Lowe DG, Grossman AB 2000 Cyclin D and cyclin E expression in normal and adenomatous pituitary. Eur J Endocrinol 143:R1-R6
23. Hendricks KB, Shanahan F, Lees E 2004 Role for BRG1 in cell cycle control and tumor suppression. Mol Cell Biol 24:362-376 (Pubitemid 38010061)
24. Vallette-Kasic S, Figarella-Branger D, Grino M, Pulichino AM, Dufour H, Grisoli F, Enjalbert A, Drouin J, Brue T 2003 Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs. J Clin Endocrinol Metab 88:3050-3056 (Pubitemid 36877471)
25. Kronenwett U, Castro J, Roblick UJ, Fujioka K, Ostring C, Faridmoghaddam F, Laytragoon-Lewin N, Tribukait B, Auer G 2003 Expression of cyclins A, E and topoisomerase II alpha correlates with centrosome amplification and genomic instability and influences the reliability of cytometric S-phase determination. BMC Cell Biol 4:8
26. Koutsami MK, Tsantoulis PK, Kouloukoussa M, Apostolopoulou K, Pateras IS, Spartinou Z, Drougou A, Evangelou K, Kittas C, Bartkova J, Bartek J, Gorgoulis VG 2006 Centrosome abnormalities are frequently observed in non-small-cell lung cancer and are associated with aneuploidy and cyclin E overexpression. J Pathol 209:512-521
27. Spruck CH, Won KA, Reed SI 1999 Deregulated cyclin E induces chromosome instability. Nature 401:297-300
28. Fukasawa K 2005 Centrosome amplification, chromosome instability and cancer development. Cancer Lett 230:6-19
29. Ganem NJ, Godinho SA, Pellman D 2009 A mechanism linking extra centrosomes to chromosomal instability. Nature 460:278-282
30. Bilodeau S, Roussel-Gervais A, Drouin J 2009 Distinct developmental roles of cell cycle inhibitors p57Kip2 and p27Kip1 distinguish pituitary progenitor cell cycle exit from cell cycle re-entry of differentiated cells. Mol Cell Biol 29:1895-1908
31. Chien WM, Garrison K, Caufield E, Orthel J, Dill J, Fero ML 2007 Differential gene expression of p27Kip1 and Rb knockout pituitary tumors associated with altered growth and angiogenesis. Cell Cycle 6:750-757
32. Lloyd RV, Ruebel KH, Zhang S, Jin L 2002 Pituitary hyperplasia in glycoprotein hormone α subunit-, p18(INK4C)-, and p27(kip-1)-null mice: analysis of proteins influencing p27(kip-1) ubiquitin degradation. Am J Pathol 160:1171-1179
33. Fauquier T, Rizzoti K, Dattani M, Lovell-Badge R, Robinson IC 2008 SOX2-expressing progenitor cells generate all of the major cell types in the adult mouse pituitary gland. Proc Natl Acad Sci USA 105:2907-2912
34. Geng Y, Yu Q, Sicinska E, Das M, Schneider JE, Bhattacharya S, Rideout WM, Bronson RT, Gardner H, Sicinski P 2003 Cyclin E ablation in the mouse. Cell 114:431-443
35. Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE 1997 Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev 11:1464-1478
36. Müller D, Bouchard C, Rudolph B, Steiner P, Stuckmann I, Saffrich R, Ansorge W, Huttner W, Eilers M 1997 Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes. Oncogene 15:2561-2576
37. Ikeda H, Yoshimoto T, Shida N 1997 Molecular analysis of p21 and p27 genes in human pituitary adenomas. Br J Cancer 76:1119-1123
38. Tanaka C, Yoshimoto K, Yang P, Kimura T, Yamada S, Moritani M, Sano T, Itakura M 1997 Infrequent mutations of p27Kip1 gene and trisomy 12 in a subset of human pituitary adenomas. J Clin Endocrinol Metab 82:3141-3147 (Pubitemid 27385689)
39. Yoshino A, Katayama Y, Ogino A, Watanabe T, Yachi K, Ohta T, Komine C, Yokoyama T, Fukushima T 2007 Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas. J Neurooncol 83:153-162
40. Lidhar K, Korbonits M, Jordan S, Khalimova Z, Kaltsas G, Lu X, Clayton RN, Jenkins PJ, Monson JP, Besser GM, Lowe DG, Grossman AB 1999 Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors. J Clin Endocrinol Metab 84:3823-3830
41. Mastronardi L, Guiducci A, Spera C, Puzzilli F, Liberati F, Maira G 1999 Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody. J Clin Pathol 52:107-111
42. Korbonits M, Chahal HS, Kaltsas G, Jordan S, Urmanova Y, Khalimova Z, Harris PE, Farrell WE, Claret FX, Grossman AB 2002 Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors. J Clin Endocrinol Metab 87:2635-2643
43. Mazumder S, DuPree EL, Almasan A 2004 A dual role of cyclin E in cell proliferation and apoptosis may provide a target for cancer therapy. Curr Cancer Drug Targets 4:65-75
44. Nishimura T, Takahashi M, Kim HS, Mukai H, Ono Y 2005 Centrosome-targeting region of CG-NAP causes centrosome amplification by recruiting cyclin E-cdk2 complex. Genes Cells 10:75-86
45. Szymas J, Schluens K, Liebert W, Petersen I 2002 Genomic instability in pituitary adenomas. Pituitary 5:211-219
46. Chesnokova V, Melmed S 2009 Pituitary tumour-transforming gene (PTTG) and pituitary senescence. Horm Res 71(Suppl 2):82-87
47. Dworakowska D, Grossman AB 2009 The pathophysiology of pituitary adenomas. Best Pract Res Clin Endocrinol Metab 23:525-541
48. Geng Y, Lee YM, Welcker M, Swanger J, Zagozdzon A, Winer JD, Roberts JM, Kaldis P, Clurman BE, Sicinski P 2007 Kinase-independent function of cyclin E. Mol Cell 25:127-139
49. Fujita M, Takeshita H, Sawa H 2007 Cyclin E and CDK2 repress the terminal differentiation of quiescent cells after asymmetric division in C. elegans. PLoS ONE 2:e407
50. Berger C, Pallavi SK, Prasad M, Shashidhara LS, Technau GM 2005 A critical role for cyclin E in cell fate determination in the central nervous system of Drosophila melanogaster. Nat Cell Biol 7:56-62
51. Lavoie PL, Budry L, Balsalobre A, Drouin J 2008 Developmental dependence on NurRE and EboxNeuro for expression of pituitary POMC. Mol Endocrinol 22:1647-1657
52. Tremblay Y, Tretjakoff I, Peterson A, Antakly T, Zhang CX, Drouin J 1988 Pituitary-specific expression and glucocorticoid regulation of proopiomelanocortin fusion gene in transgenic mice. Proc Natl Acad Sci USA 85:8890-8894
53. Lamolet B, Pulichino AM, Lamonerie T, Gauthier Y, Brue T, Enjalbert A, Drouin J 2001 A pituitary cell-restricted T-box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 104:849-859
54. Rambaud J, Desroches J, Balsalobre A, Drouin J 2009 TIF1β/KAP-1 is a coactivator of the orphan nuclear receptor NGFI-B/Nur77. J Biol Chem 284:14147-14156
55. Lanctôt C, Lamolet B, Drouin J 1997 The bicoid-related homeoprotein Ptx1 defines the most anterior domain of the embryo and differentiates posterior from anterior lateral mesoderm. Development 124:2807-2817